Zhejiang Jingxin`s Generic Colesevelam Hydrochloride Receives Approval In US
21 Jul 2020 //
FDA
China`s generic drug makers struggle to survive bulk-buy policy onslaught
02 Jan 2019 //
JAPAN TIMES
Mapi Pharma raises $10M from Jingxin
08 Nov 2018 //
BIOSPECTRUM
M&A this week: Oxis International, Hangzhou Tianmushan, Zhejiang Jingxin Pharmaceutical
30 Jun 2017 //
PHARMACEUTICAL